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Abstract
Background: Methicillin-resistant Staphylococcus aureus is a serious cause of morbidity and mortality in hospital
environment, but also, lately, in the community. This case report is, to our knowledge, the first detailed description
of a community-associated methicillin-resistant S. aureus ST80 orbital cellulitis in a previously healthy neonate.
Possible predisposing factors of microbial acquisition and treatment selection are also discussed.
Case presentation: A 28-day-old Caucasian boy was referred to our hospital with the diagnosis of right orbital
cellulitis. His symptoms included right eye proptosis, periocular edema and redness. Empirical therapy of
intravenous daptomycin, rifampin and ceftriaxone was initiated. The culture of pus yielded a methicillin-resistant S.
aureus isolate and the molecular analysis revealed that it was a Panton-Valentine leukocidine-positive ST80 strain.
The combination antimicrobial therapy was continued for 42 days and the infection was successfully controlled.
Conclusions: Clinicians should be aware that young infants, even without any predisposing condition, are
susceptible to orbital cellulitis caused by community-associated methicillin-resistant S. aureus. Prompt initiation of
the appropriate empirical therapy, according to the local epidemiology, should successfully address the infection,
preventing ocular and systemic complications.
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Background
Over the past 2 decades, the incidence of community-asso-
ciated methicillin-resistant Staphylococcus aureus (CA-
MRSA) infections has constantly been rising, due to the
emergence of highly virulent and transmissible strains [1].
In a recent study performed in our area, CA-MRSA was
found to be increasing as a cause of skin and soft tissue
infections, as well as of the invasive ones, among all
pediatric ages [2]. Fortunov et al. have reported that CA-
MRSA infections are also increasing in previously healthy
neonates without traditional risk factors and males are
most often affected between 7 to 12 days of age [3,4].
Greece is a country with increased incidence of CA-
MRSA. This expansion is associated mainly with the
wide spread in the community of a single virulent clone,
the European ST80. In our area, the proportion of
staphylococcal pediatric infections caused by a CA-
MRSA isolate increased from 51.5% in 2003–2006 to
63.4% in 2007–2009 [2]. In addition, an increasing rate
of resistance to clindamycin has been noted. The rate of
clindamycin resistance in MRSA isolates between 2007
and 2009 has been 23.8–31.2% and that of MSSA isolates
15.4–38.1% [2]. Currently in central Greece, vancomycin,
linezolid, or daptomycin [5,6], as monotherapy or in
combination with rifampin or gentamicin, appear to be
choices for empirical therapy of severe possible staphylo-
coccal pediatric infections.
Cases of CA-MRSA periocular infections in pediatric
patients have been reported, the most recent being a re-
port of two cases of infantile CA-MRSA orbital cellulitis
by Kobayashi et al. [7]. Kodsi reported a case of chronic
dacryocystitis due to CA-MRSA in an 8.5-month-old boy
with congenital nasolacrimal duct obstruction [8].
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Another case of perinatal CA-MRSA dacryocystitis and
periorbital cellulitis in a 12-day-old previously healthy
neonate has recently been reported [9]. In this patient,
vertical transmission of MRSA may have occurred during
vaginal delivery or subsequent close contact, including
breast feeding.
Mother, during or after delivery, family members or birth
in the hospital may be implicated in CA-MRSA acquisi-
tion. An interesting study of more than 5,000 pregnant
women proved that 3.5% of them had vaginal colonization
with MRSA. There was no evidence of MRSA disease
among their newborn children [10]. These findings, how-
ever, suggest that vertical transmission of MRSA is theor-
etically possible during vaginal delivery.
A recent study of Fortunov et al. revealed that healthy
term and late preterm neonates were more often infected
by S. aureus with their own nasal strain than with their
mother’s nasal strain [11].
In order to highlight the wide age and clinical mani-
festation spectrum of CA-MRSA infections, we report a
case of perinatally acquired MRSA orbital cellulitis.
Case presentation
Our patient, a 28-day-old boy, was referred to the De-
partment of Pediatrics of our hospital with the diagnosis of
right-sided orbital cellulitis on April 28, 2010. His symp-
toms, including anorexia, rhinorrhoea, and right eye red-
ness had begun five days before admission.
The newborn was full-term and had been delivered va-
ginally. Birth weight was 4,900 g and he was on com-
bined breast and formula feeding pattern.
On admission, the patient’s temperature was 37.7°C,
heart rate was 132 beats/min, and physical examination
revealed no other pathological findings except right eye
proptosis, conjunctival injection and periorbital erythema.
The infant did not have evidence of pneumonia on chest
radiograph.
White blood cell count was 19,000 cells/mm
3 with dif-
ferential of neutrophils 49%, lymphocytes 24%, monocytes
11%, activated lymphocytes 10%, myelocytes 1% and eosi-
nophils 5%. Platelet count was 373,000/mm
3. Blood,
urine, and cerebrospinal fluid (CSF) samples were cul-
tured and proved sterile. The examination of CSF showed
300 RBC/mm
3, 2 WBC/mm
3, glucose 3.88 mmol/L with
concomitant blood glucose 6.55 mmol/L, protein 0.52 g/L
and LDH 24 IU/L. Erythrocyte sedimentation rate (ESR)
was 91 mm/h and C-reactive protein (CRP) was 120 mg/L.
Ophthalmic examination revealed right eye proptosis,
periocular redness and edema and conjunctival discharge.
Ocular motility was severely impaired. Pupils were equal,
round, normally reactive to light. Slit-lamp anterior seg-
ment examination and dilated fundus examination were
within normal limits.
Brain MRI was normal and orbital MRI at 3.0 T showed
ethmoid opacification and a right eye proptosis due to an
intra-orbital lesion, located in the retrobulbar fatty tissue
between the medial, lateral, inferior rectus muscles and
the wall of the globe. The lesion, containing multiple cys-
tic regions, was consistent with orbital cellulitis with ab-
scess formation (Figure 1).
Empirical therapy of intravenous daptomycin 12 mg/kg
qd, rifampin 20 mg/kg qd and ceftriaxone 100 mg/kg qd
was initiated. On the fifth day of treatment, as the ab-
scess had expanded to the preseptal area and the right eye
proptosis continued with tension and edema of the lower
eyelid, surgical drainage was performed through the inner
area of the lower fornix. The culture of pus yielded a low
colony count of MRSA. Polymerase chain reaction was per-
formed in order to test the isolate for genes encoding the
Panton-Valentine leukocidine (PVL) production (luk-S-PV
and luk-F-PV) as previously described [2]. In addition, the
S. aureus strain was studied by multilocus sequence typ-
ing. The molecular analysis of the isolate revealed that it
was a PVL-positive ST80 S. aureus strain. The isolate was
resistant to oxacillin, tetracycline and fucidic acid and sus-
ceptible to erythromycin, trimethoprim/sulfamethoxazole,
Figure 1 Initial Orbit MRI. Axial T1 post Gd MR image shows
unilateral exophthalmos of the right eye due to inflammatory
collections with central liquification and peripheral enhancement
suggestive of a multiloculated abscess that occupy the inferior and
posterolateral aspect of the orbit. The adjacent ethmoid sinuses are
extensively mucus-filled with heterogeneous enhancement,
consistent with sinusitis.
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floxacin. The MIC to daptomycin was determined by the
E-test method (AB Biodisk, Solna, Sweden) and was found
to be 0.19 mg/L.
The infant remained afebrile. Further drainage of a
small quantity of pus from the previously incised area was
performed on the sixth day of treatment. Orbital MRI was
performed the following day, revealing reduction of the
abscess cavity volume, particularly at the posterolateral as-
pect of the orbit.
ESR was 40 mm/h and CRP was 3 mg/L on the eighth
day of treatment and on the 15th day, ESR was 21 mm/h
and CRP decreased to 0.1 mg/L.
During the following weeks, his ophthalmic findings
were gradually improved without requirement for further
surgery. The edema of the lower eyelid subsided fully dur-
ing the fourth week of treatment. A repeat MRI was per-
formed after 4 weeks of antimicrobial therapy, in which
residual inflammatory findings were observed in the
inferolateral structures of the orbit.
The combination antimicrobial therapy was administered
for 42 days and successfully controlled the infection. The
patient tolerated well the 6-week daptomycin therapy. The
infant had normal creatinine and blood urea nitrogen
values. No increase in serum creatine phosphokinase (CPK)
levels was noted. CPK level was measured at least once per
week and it ranged from 31 to 113 IU/L (median value
87 IU/L). A follow-up evaluation was performed 4 weeks
after the completion of antimicrobial therapy and both the
clinical examination and MRI findings were normal with-
out residual ophthalmic disease. Since then, no relapse or
long-term ophthalmic sequelae have been observed.
Maternal medical history and the thorough clinical in-
vestigation failed to reveal obvious predisposing factors
of CA-MRSA acquisition or the site of entrance.
Conclusions
Clinicians should be aware that young infants, even with-
out any predisposing condition, are susceptible to orbital
cellulitis caused by CA-MRSA. Moreover, in these cases
the way of microbial acquisition or the site of entrance
may remain unclear.
In a serious infection, such as orbital cellulitis, the follow-
ing indications should be carefully considered as to when to
initiate empirical treatment against CA-MRSA: (1) clinical
suspicion or imaging findings consistent with orbital ab-
scess; (2) extreme ages, such as infants under 3 months of
age, especially during the neonatal period; and (3) an area
where MRSA infections are not rare (prevalence of >5%).
In areas like our geographic region, where European
ST80 CA-MRSA is endemic as a cause of skin and soft
tissue as well as of invasive infections, empirical therapy
with agents active against CA-MRSA should be initiated
immediately in cases of orbital cellulitis.
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